Search for Clinical Trial Results

Sponsored By

Glomerulonephritis, Membranous - 23 Studies Found

Status Study
Completed Study Name: Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Date: 2005-08-25
Interventions: Drug: Cyclophosphamide and steroids comparison of difference in time of start of therapy
Completed Study Name: Mycophenolate Mofetil in Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Date: 2005-08-25
Interventions:
  • Drug: mycophenolate mofetil orally 1000 mg twice a day (BID)
Recruiting Study Name: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Date: 2011-01-19
Interventions:
  • Drug: Mycophenolate mofetil, low dose steroid

Withdrawn Study Name: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Date: 2013-01-04
Interventions:
  • Drug: Belimumab 10 mg Belimuma
Active, not recruiting Study Name: MEmbranous Nephropathy Trial Of Rituximab
Condition: Idiopathic Membranous Nephropathy
Date: 2010-08-10
Interventions:
  • Drug: Rituximab 1000 mg, I.V.

Withdrawn Study Name: Aliskiren in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2010-03-24
Interventions: Drug: Aliskiren Aliskiren dose will begin with 150mg per day and later up-titrated to the maximum availa
Not yet recruiting Study Name: Adrenocorticotropic Hormone in Membranous Nephropathy
Condition: Membranous Nephropathy
Date: 2017-01-17
Interventions: Drug: ACTHar for 6 months Other Names:
Active, not recruiting Study Name: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2011-12-09
Interventions:
  • Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, An
Recruiting Study Name: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
Condition: MEMBRANOUS NEPHROPATHY
Date: 2013-09-19
Interventions:
  • Drug: TACROLIMUS Initial dose:
Active, not recruiting Study Name: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2013-04-29
Interventions:
  • Drug: Losartan Tablets & QingReMoShen Granule
Next >>>